- Gastrointestinal safety of amtolmetin guacyl in comparison with celecoxib in patients with rheumatoid arthritisZ Jajic
Department for Rheumatology, Physical Medicine and Rehabilitation, Medical Faculty University of Zagreb, Referral Centre for Inflammatory Rheumatic Disease, Zagreb, Croatia
Clin Exp Rheumatol 23:809-18. 2005..The primary end-point of this study was to evaluate the gastrointestinal safety of amtolmetin guacyl in comparison with celecoxib in patients affected with rheumatoid arthritis. The assessment of efficacy was the secondary end-point...